Published in Clin Cancer Res on October 15, 2006
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Animal models of cancer pain. Comp Med (2008) 1.35
Endothelin receptors and pain. J Pain (2009) 1.27
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer. Pain Med (2008) 1.01
Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma. Gut Liver (2015) 0.85
Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Support Care Cancer (2008) 0.84
Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) (2011) 0.83
Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice. J Clin Med (2014) 0.82
Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model. Mol Pain (2010) 0.82
The role of the bone microenvironment in skeletal metastasis. J Bone Oncol (2012) 0.79
125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments. Oncotarget (2016) 0.78
Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain. Pain (2017) 0.75
The spine instability neoplastic score (SINS) in the assessment of response to radiotherapy for bone metastases. Clin Transl Oncol (2017) 0.75
Computed tomography-guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer. Skeletal Radiol (2015) 0.75
Molecular mechanisms of cancer pain. Nat Rev Cancer (2002) 1.62
Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: what are the long-term implications? J Clin Oncol (2002) 1.43
Pilot study of vascular health in survivors of osteosarcoma. Pediatr Blood Cancer (2013) 1.42
Gene expression in giant-cell tumors. J Lab Clin Med (2004) 1.26
Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study. Cancer (2003) 1.26
Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain (2002) 1.09
Intramuscular hemangioma: recurrence risk related to surgical margins. Clin Orthop Relat Res (2007) 1.06
Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest (2005) 1.05
Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene. Cancer Res (2003) 0.98
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors. Cancer Chemother Pharmacol (2009) 0.97
2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cancer Res (2007) 0.92
Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery. Clin Orthop Relat Res (2002) 0.92
Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone. Eur J Cancer (2008) 0.91
Radiation treatment decreases bone cancer pain through direct effect on tumor cells. Radiat Res (2005) 0.90
A suspicious vulvar mass diagnosed as a subpubic cartilaginous cyst. Arch Gynecol Obstet (2008) 0.87
Novel cytosine deaminase fusion gene enhances the effect of radiation on breast cancer in bone by reducing tumor burden, osteolysis, and skeletal fracture. Clin Cancer Res (2006) 0.85
Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice. J Biol Chem (2004) 0.82
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clin Cancer Res (2006) 0.80
Management of Unplanned Excision for Soft-Tissue Sarcoma With Preoperative Radiotherapy Followed by Definitive Resection. Am J Clin Oncol (2016) 0.80
Osteoclasts direct bystander killing of bone cancer. Cancer Res (2006) 0.80
Osteoclasts direct bystander killing of cancer cells in vitro. Bone (2005) 0.78
Lentivirus transduction of human osteoclast precursor cells and differentiation into functional osteoclasts. Bone (2011) 0.78
Local irradiation in combination with bevacizumab enhances radiation control of bone destruction and cancer-induced pain in a model of bone metastases. Int J Cancer (2008) 0.78
Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas. Clin Orthop Relat Res (2014) 0.78
A customized retroviral vector confers marker gene expression in osteoclast lineage cells. J Cell Biochem (2006) 0.75
Forearm mass in an adolescent. Clin Orthop Relat Res (2007) 0.75